← Open Payments lookup

AYOOLA OYENUGA: Open Payments

NPI 1982172664 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,258 in 36 payments from 7 companies in 2025. Trend: 2023 $311 · 2024 $549 · 2025 $1,258

Food & beverage: $1,258
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$445
Otsuka America Pharmaceutical, Inc.3$252
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$210
ABBVIE INC.10$159
E.R. Squibb & Sons, L.L.C.2$135
Alkermes, Inc.2$36
Teva Pharmaceuticals USA, Inc.1$21

Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.